Racial/ethnic differences in shared decision making about cardiovascular risk-reduction therapy could affect health disparities.
Objective
To investigate whether patient race/ethnicity is associated with experiences discussing cardiovascular risk-reduction therapy with health care providers.
Setting
National sample of US adults identified by random-digit dialing.
Design
Cross-sectional survey conducted in November 2006 to May 2007.
Participants
Among participants in the National Survey of Medical Decisions (DECISIONS), a nationally representative sample of English-speaking US adults aged 40 and older, the authors analyzed respondents who reported discussing hyperlipidemia or hypertension medications with a health care provider in the previous 2 years.
Measurements
In multivariate linear and logistic regressions adjusting for age, gender, income, insurance status, perceived health, and current therapy, they assessed the relation between race/ethnicity (black/Hispanic v. white) and decision making: knowledge, discussion of pros and cons of therapy, discussion of patient preference, who made the final decision, preferred involvement, and confidence in the decision.
Results
Of respondents who discussed high cholesterol (N = 738) or hypertension (N = 745) medications, 88% were white, 9% black, and 4% Hispanic. Minorities had lower knowledge scores than whites for hyperlipidemia (42% v. 52%, difference –10% [95% confidence interval (CI): 15, –5], P < 0.001), but not for hypertension. For hyperlipidemia, minorities were more likely than whites to report that the health care provider made the final decision for treatment (31.7% v. 12.3% whites, difference 19.4% [95% CI: 6.9, 33.1%], P < 0.01); this was not true for hypertension.
Limitations
Possible limitations include the small percentage of minorities in the sample and potential recall bias.
Conclusions
Minorities considering hyperlipidemia therapy may be less informed about and less involved in the final decision-making process.
WongMD, ShapiroMF, BoscardinWJ, EttnerSL.Contribution of major diseases to disparities in mortality. N Engl J Med.2002; 347: 1585–92.
2.
MensahGA, MokdadAH, FordES, GreenlundKJ, CroftJB.State of disparities in cardiovascular health in the United States. Circulation.2005; 111: 1233–41.
3.
TrivediAN, ZaslavskyAM, SchneiderEC, AyanianJZ.Relationship between quality of care and racial disparities in Medicare health plans. JAMA.2006; 296: 1998–2004.
4.
SequistTD, AdamsA, ZhangF, Ross-DegnanD, AyanianJZ.Effect of quality improvement on racial disparities in diabetes care. Arch Intern Med.2006; 166: 675–81.
5.
BenjaminEJ, JessupM, FlackJM.Discovering the full spectrum of cardiovascular disease: Minority health summit 2003: Report of the outcomes writing group. Circulation.2005; 111: e124–33.
6.
Centers for Disease Control and Prevention (CDC).Disparities in screening for and awareness of high blood cholesterol—United States, 1999-2002. MMWR Morb Mortal Wkly Rep.2005; 54: 117–9.
7.
MaJ, SehgalNL, AyanianJZ, StaffordRS.National trends in statin use by coronary heart disease risk category. PLoS Med.2005; 2: e123.
8.
O'MearaJG, KardiaSL, ArmonJJ, BrownCA, BoerwinkleE, TurnerST.Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med.2004; 164: 1313–8.
9.
HyreAD, MuntnerP, MenkeA, RaggiP, HeJ.Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol.2007; 17: 548–55.
10.
HertzRP, UngerAN, CornellJA, SaundersE.Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med.2005; 165: 2098–104.
11.
KramerH, HanC, PostW.Racial/ethnic differences in hypertension and hypertension treatment and control in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens.2004; 17: 963–70.
12.
HymanDJ, PavlikVN.Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med.2001; 345: 479–86.
13.
HarmonG, LefanteJ, Krousel-WoodM.Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications. Curr Opin Cardiol.2006; 21: 310–5.
14.
OsterbergL, BlaschkeT.Adherence to medication. N Engl J Med.2005; 353: 487–97.
15.
Sheridan SL, Harris RP, Woolf SH, Shared Decision-Making Workgroup of the U.S. Preventive Services Task Force.Shared decision making about screening and chemoprevention. A suggested approach from the U.S. Preventive Services Task Force. Am J Prev Med.2004; 26: 56–66.
16.
NaikAD, KallenMA, WalderA, StreetRLJr. Improving hypertension control in diabetes mellitus: the effects of collaborative and proactive health communication. Circulation.2008; 117: 1361–8.
17.
LevinsonW, KaoA, KubyA, ThistedRA.Not all patients want to participate in decision making. A national study of public preferences. J Gen Intern Med.2005; 20: 531–5.
18.
Zikmund-FisherBJ, CouperMP, SingerE.The DECISIONS study: A nationwide survey of United States adults regarding 9 common medical decisions. Med Decis Making.2010; 30: 20S–34S.
19.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation.2002; 106: 3143–421.
20.
PignoneM, PhillipsC, MulrowC.Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. BMJ.2000; 321: 983–6.
21.
ThavendiranathanP, BagaiA, BrookhartMA, ChoudhryNK.Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med.2006; 166: 2307–13.
22.
PasternakRC, SmithSCJr, Bairey-MerzCN.ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Stroke.2002; 33: 2337–41.
23.
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med.1997; 157: 2413–46.
24.
ChobanianAV, BakrisGL, BlackHR.The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA.2003; 289: 2560–72.
25.
MulrowCD, PignoneM.What are the elements of good treatment for hypertension?BMJ.2001; 322: 1107–9.
26.
GueyffierF, BoutitieF, BoisselJ P.Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. the INDANA investigators. Ann Intern Med.1997; 126: 761–7.
27.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration.Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet.2002; 360: 1903–13.
28.
SchwartzLM, WoloshinS, WelchHG.Misunderstandings about the effects of race and sex on physicians’ referrals for cardiac catheterization. N Engl J Med.1999; 341: 279–83; discussion 286-7.
29.
DaviesHT, CrombieIK, TavakoliM.When can odds ratios mislead?BMJ.1998; 316: 989–91.
30.
The American Association for Public Opinion Research.Standard Definitions; Final Dispositions of Case Codes and Outcome Rates for Surveys, 4th Edition. Deerfield, IL; 2006.
31.
Centers for Disease Control and Prevention (CDC).Trends in cholesterol screening and awareness of high blood cholesterol—United States, 1991-2003. MMWR Morb Mortal Wkly Rep.2005; 54: 865–70.
32.
WallaceLS, DeVoeJE, RogersES, Malagon-RogersM, FryerGEJr. The medical dialogue: disentangling differences between Hispanic and non-Hispanic whites. J Gen Intern Med.2007; 22: 1538–43.
33.
JohnsonRL, RoterD, PoweNR, CooperLA.Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Public Health.2004; 94: 2084–90.
34.
KressinNR, WangF, LongJ.Hypertensive patients’ race, health beliefs, process of care, and medication adherence. J Gen Intern Med.2007; 22: 768–74.
35.
OstchegaY, DillonCF, HughesJP, CarrollM, YoonS.Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc.2007; 55: 1056–65.
36.
DouglasJG, BakrisGL, EpsteinM.Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med.2003; 163: 525–41.
37.
JamersonK, DeQuattroV.The impact of ethnicity on response to antihypertensive therapy. Am J Med.1996; 101: 22S–32S.
38.
NHLBl's Healthy People 2010 Minority Populations Gateway page. National Heart Blood Lung Institute Web site. Available at: http://hp2010.nhlbihin.net/minority/minmain.htm. Accessed August 10, 2010.
39.
KripalaniS, YaoX, HaynesRB.Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med.2007; 167: 540–50.
40.
SabaGW, WongST, SchillingerD.Shared decision making and the experience of partnership in primary care. Ann Fam Med.2006; 4: 54–62.
41.
BosworthHB, DudleyT, OlsenMK.Racial differences in blood pressure control: potential explanatory factors. Am J Med.2006; 119: 70.e9-70.15.
42.
Centers for Disease Control and Prevention (CDC).Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years—United States, 2004-2005. MMWR Morb Mortal Wkly Rep.2006; 55: 1065–8.
43.
Centers for Disease Control and Prevention (CDC).Use of mammograms among women aged > or = 40 years—United States, 2000-2005. MMWR Morb Mortal Wkly Rep.2007; 56: 49–51.
44.
Centers for Disease Control and Prevention.2006 Behavioral Risk Factor Surveillance System Summary Data Quality ReportAtlanta, Ga: Center for Disease Control and Prevention.2007.
